AUDENZ (NATIONAL STOCKPILE) (influenza A (H5N1) vaccine mvs (6mos up)/adjuvant MF59C.1/PF)
INFLUENZA VACCINE·AVIAN INFLUENZA (H5N1) VACCINATION
SEQIRUS, INC.
Indication
Avian influenza (H5N1) vaccination
Avian influenza (H5N1) vaccination is an active immunization indication intended for the prevention of infection and disease caused by the highly pathogenic avian influenza A virus subtype H5N1. Read more about Avian influenza (H5N1) vaccination
1 drugs 1 manufacturers
Drugs that treat it
Common Avian influenza (H5N1) vaccination therapies.
Filter & compare in the drug finder →Opens the drug finder with Avian influenza (H5N1) vaccination preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAvian influenza (H5N1) vaccination is an active immunization indication intended for the prevention of infection and disease caused by the highly pathogenic avian influenza A virus subtype H5N1.
Infection predominantly compromises the human respiratory tract, manifesting along a wide spectrum that ranges from conjunctivitis and mild influenza-like upper respiratory symptoms to severe viral pneumonia, acute respiratory distress syndrome, multiorgan failure, and death.
Pathophysiologically, the virus binds avian-like alpha-2,3-linked sialic acid receptors in the lower respiratory tract, frequently triggering intense, dysregulated hypercytokinemia—a "cytokine storm"—and profound alveolar damage.
This preventive indication is typically reserved for populations at elevated risk of zoonotic exposure, such as laboratory and agricultural personnel working with infected animal reservoirs, or deployed in public health preparedness stockpiles to mitigate potential pandemic spread.
- fda.gov
Avian influenza (H5N1) vaccination is an active immunization indication intended for the prevention of infection and disease caused by the highly pathogenic avian influenza A virus subtype H5N1 This preventive indication is typically reserved for populations at elevated risk of zoonotic exposure, such as laboratory and agricultural personnel working with infected animal reservoirs, or deployed in public health preparedness stockpiles to mitigate potential pandemic spread
- fda.gov
Avian influenza (H5N1) vaccination is an active immunization indication intended for the prevention of infection and disease caused by the highly pathogenic avian influenza A virus subtype H5N1
- cdc.gov
Infection predominantly compromises the human respiratory tract, manifesting along a wide spectrum that ranges from conjunctivitis and mild influenza-like upper respiratory symptoms to severe viral pneumonia, acute respiratory distress syndrome, multiorgan failure, and death
- geph.ca
This preventive indication is typically reserved for populations at elevated risk of zoonotic exposure, such as laboratory and agricultural personnel working with infected animal reservoirs, or deployed in public health preparedness stockpiles to mitigate potential pandemic spread
Personalize your experience
Follow Avian influenza (H5N1) vaccination and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.